TF information
| TF name: | CEBPD |
| TF family: | TF_bZIP |
| Ensembl gene ID: | ENSG00000221869 |
| Ensembl protein ID: | ENSP00000386165 |
| Entrez gene ID: | 1052 |
| Database name | Link | Database name | Link |
| NCBI Gene: |  |
Genecards: |  |
| Uniprot: |  |
Wikipedia: |  |
| Cosmic 3D: |  |
Geneontology: |  |
| CCLE: |  |
Frequency of CEBPD in all biosamples
| Sample ID | Biosample type | Tissue type | Biosample name | TF Frequency |
|---|---|---|---|---|
| Sample_02_166 | Cell line | Mammary Gland | HCC1954_Parental | 0.096 |
CEBPD distribution in samples’ most representative CRC
| Sample ID | Tissue type | Biosample type | Biosample name |
|---|---|---|---|
| Sample_02_166 | Mammary Gland | Cell line | HCC1954_Parental |
CEBPD distribution in all CRCs
Genomic distribution of SEs associated with CEBPD
Genomic distribution of SEs associated with TF
Figure legend:
Genomic distribution of SEs associated with TF: It can roughly understand the genomic regions of SEs associated with TF, and help to carry out the next analysis, such as knocking down the experiment.
What is important information?
The yellow box can be thought of as the common genomic regions that regulates the SEs associated with TF. For example, if a knockdown experiment is performed on this region, then theoretically, the expression of the TF will be greatly reduced.
| Database name | Link |
|---|---|
| Cosmic: |  |
| Cosmic cell lines: |  |
| Depmap: |  |
TCGA somatic mutations and clinical variants of CEBPD
| rsID | Chr | Start | Stop | Ref | Alt | Gene_region | Gene_symble | Effect | TCGA_Occurrence |
|---|---|---|---|---|---|---|---|---|---|
| - | chr8 | 48649914 | 48649914 | G | C | exonic | CEBPD | nonsynonymous | LUAD|1|543|0.00184 |
| - | chr8 | 48650481 | 48650481 | T | C | exonic | CEBPD | nonsynonymous | HNSC|1|512|0.00195 |
| rs758121344 | chr8 | 48650524 | 48650524 | G | A | exonic | CEBPD | synonymous | LUAD|2|543|0.00368 |
| - | chr8 | 48649939 | 48649939 | C | A | exonic | CEBPD | synonymous | HNSC|2|512|0.00391 |
| - | chr8 | 48650425 | 48650425 | G | A | exonic | CEBPD | synonymous | HNSC|1|512|0.00195 |
| TF_name | Disease_name | Disease_class | Disease_semantic_type | TF_disease_source |
|---|---|---|---|---|
| CEBPD | Leukemia, Myelocytic, Acute | C04 | Neoplastic Process | CTD_human |
| CEBPD | Liver Cirrhosis, Experimental | C06 | Experimental Model of Disease | CTD_human |
| CEBPD | Acute Myeloid Leukemia, M1 | C04 | Neoplastic Process | CTD_human |
| CEBPD | Prolactinoma | C04;C10;C19 | Neoplastic Process | CTD_human |
| CEBPD | Myocardial Ischemia | C14 | Disease or Syndrome | CTD_human |
| CEBPD | Microprolactinoma | C04;C10;C19 | Neoplastic Process | CTD_human |
| CEBPD | Macroprolactinoma | C04;C10;C19 | Neoplastic Process | CTD_human |
| CEBPD | Acute Myeloid Leukemia (AML-M2) | C04 | Neoplastic Process | CTD_human |
| CEBPD | Liver carcinoma | C04;C06 | Neoplastic Process | CTD_human |
| pathway_ID | pathway_name | pathway_source | gene_number | edge_number |
|---|---|---|---|---|
| pathway0000335 | C-MYB transcription factor network | pid | 87 | 525 |
| pathway0000825 | FOXA2 and FOXA3 transcription factor networks | pid | 45 | 202 |
| pathway0001131 | IL6-mediated signaling events | pid | 48 | 426 |
| pathway0001857 | Regulation of retinoblastoma protein | pid | 67 | 718 |
| pathway0002302 | Transcriptional regulation of white adipocyte differentiation | reactome | 79 | 1522 |
| pathway0002391 | Validated targets of C-MYC transcriptional repression | pid | 63 | 385 |
| pathway0002393 | Validated transcriptional targets of deltaNp63 isoforms | pid | 47 | 101 |
| GO_term_name | GO_term_type | TF_name |
|---|